Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Keywords
essential thrombocythaemia, megakaryocytopoiesis, microvesicles, myelofibrosis, platelet activation, ruxolitinib, Blood Platelets, Female, Humans, Janus Kinases, Male, Megakaryocytes, Nitriles, Primary Myelofibrosis, Pyrazoles, Pyrimidines
Journal Title
Br J Haematol
Conference Name
Journal ISSN
0007-1048
1365-2141
1365-2141
Volume Title
185
Publisher
Wiley
Publisher DOI
Rights
All rights reserved
Sponsorship
Italian Association for Cancer Research (AIRC) (Fellowship Rif. 20930)
Medical Research Council (MC_PC_12009)
Medical Research Council (MC_PC_12009)